Top drugs by sales value in Norway 2021
The pharmaceutical with the highest sales value in Norway in 2021 was Hyrimoz, a biosimilar of Humira (adalimumab), with a sales value of 907 million Norwegian kroner. Merck & Co.'s Keytruda (pembrolizumab) followed, with a sales value of 844 million Norwegian kroner.